Search Results - "GAMBLIN, Clark"

Refine Results
  1. 1

    World Review of Laparoscopic Liver Resection: 2,804 Patients by TRI NGUYEN, Kevin, CLARK GAMBLIN, T, GELLER, David A

    Published in Annals of surgery (01-11-2009)
    “…To provide a review of the world literature on laparoscopic liver resection. Initially described for peripheral, benign tumors resected by nonanatomic wedge…”
    Get full text
    Conference Proceeding Journal Article
  2. 2

    Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review by Stein, Andrew, Strong, Erin, Clark Gamblin, T., Clarke, Callisia, Tsai, Susan, Thomas, James, George, Ben, Mogal, Harveshp

    Published in Annals of surgical oncology (2020)
    “…Introduction The role of somatic mutation profiling in the management of appendiceal mucinous tumors (AMTs) is evolving. Using a systematic review, we…”
    Get full text
    Journal Article
  3. 3

    Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines by Engelsgjerd, Samuel, Kunnimalaiyaan, Selvi, Kandil, Emad, Gamblin, T Clark, Kunnimalaiyaan, Muthusamy

    Published in PloS one (14-03-2019)
    “…High-risk neuroblastoma (NB) is lethal childhood cancer. Published data including ours have reported the anti-proliferative effect of Xanthohumol (XN), a…”
    Get full text
    Journal Article
  4. 4

    Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro by Kunnimalaiyaan, Selvi, Schwartz, Victoriana K, Jackson, Iris Alao, Clark Gamblin, T, Kunnimalaiyaan, Muthusamy

    Published in BMC cancer (11-05-2018)
    “…Neuroblastoma (NB) is a devastating disease. Despite recent advances in the treatment of NB, about 60% of high-risk NB will have relapse and therefore…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma by Miura, John T., Johnston, Fabian M., Tsai, Susan, George, Ben, Thomas, Jim, Eastwood, Dan, Banerjee, Anjishnu, Christians, Kathleen K., Turaga, Kiran K., Pawlik, Timothy M., Clark Gamblin, T.

    Published in Annals of surgical oncology (01-10-2015)
    “…Background The benefit of chemotherapy for surgically resected intrahepatic cholangiocarcinoma (ICC) remains poorly defined. The present study sought to…”
    Get full text
    Journal Article
  7. 7

    Multidisciplinary approaches to intrahepatic cholangiocarcinoma by Maithel, Shishir K., Gamblin, T. Clark, Kamel, Ihab, Corona‐Villalobos, Celia Pamela, Thomas, Melanie, Pawlik, Timothy M.

    Published in Cancer (15-11-2013)
    “…After hepatocellular carcinoma, intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy. The etiology of ICC in most…”
    Get full text
    Journal Article
  8. 8

    Importance of Histologic Subtype in the Staging of Appendiceal Tumors by Turaga, Kiran K., Pappas, Sam G., Gamblin, T. Clark

    Published in Annals of surgical oncology (01-05-2012)
    “…Background Malignant neoplasms of the appendix have different behavior based on their histologic subtypes in anecdotal series. Current staging systems do not…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Immune checkpoint inhibitors in hepatocellular carcinoma: A review of current clinical trials by Gamboa, Adriana C., Kooby, David A., Maithel, Shishir K., Gamblin, T. Clark

    Published in Journal of surgical oncology (01-01-2024)
    “…Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a poor prognosis due to advanced disease presentation or recurrence despite…”
    Get full text
    Journal Article
  12. 12

    Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression by Kunnimalaiyaan, Selvi, Clark Gamblin, T, Kunnimalaiyaan, Muthusamy

    Published in HPB (Oxford, England) (01-09-2015)
    “…Abstract Background Glycogen synthase kinase-3 (GSK-3) can act as either a tumour promoter or suppressor by its inactivation depending on the cell type. There…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Laparoscopic liver surgery: Shifting the management of liver tumors by Koffron, Alan, Geller, David, Gamblin, T. Clark, Abecassis, Michael

    Published in Hepatology (Baltimore, Md.) (01-12-2006)
    “…Laparoscopic liver surgery has evolved rapidly over the past 5 years in a select number of centers. The growing experience with these procedures has resulted…”
    Get full text
    Journal Article
  15. 15

    Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma by Walden, Daniel, Kunnimalaiyaan, Selvi, Sokolowski, Kevin, Clark, T Gamblin, Kunnimalaiyaan, Muthusamy

    Published in Oncotarget (20-10-2017)
    “…Cholangiocarcinoma remains the second most prevalent hepatic neoplasm in the United States with a 5-year survival rate of less than 10%. Currently, no systemic…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Elective Regional Therapy Treatment for Hepatic Adenoma by Silva, Jack P., Klooster, Brittany, Tsai, Susan, Christians, Kathleen K., Clarke, Callisia N., Mogal, Harveshp, Clark Gamblin, T.

    Published in Annals of surgical oncology (01-01-2019)
    “…Background Locoregional therapy treatments for hepatic adenoma (HA) are typically limited to selective hepatic arterial embolization (HAE) to control acute…”
    Get full text
    Journal Article
  19. 19
  20. 20